Next Article in Journal
The Effect of Chronic Graft-Versus-Host Disease and Its Therapy on Salivary Caries Risk Factors—An Exploratory Cross-Sectional Pilot Study
Previous Article in Journal
Assisted Suicide and Suicide Prevention: Ethical Perspectives, Attitudes and Challenges for Nurses in Long-Term Care—A Qualitative Focus Group Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Beyond Pain Relief: A Cross-Sectional Study on NSAID Prescribing, Polypharmacy, and Drug Interaction Risks in Community Pharmacies

by
Javedh Shareef
*,
Sathvik Belagodu Sridhar
*,
Saeed Humaid Al Naqbi
and
Adyan Iftekhar Bakshi
Clinical Pharmacy & Pharmacology, Ras Al Khaimah College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates
*
Authors to whom correspondence should be addressed.
Healthcare 2025, 13(24), 3264; https://doi.org/10.3390/healthcare13243264
Submission received: 28 October 2025 / Revised: 29 November 2025 / Accepted: 9 December 2025 / Published: 12 December 2025
(This article belongs to the Section Healthcare Quality, Patient Safety, and Self-care Management)

Abstract

Background/Objectives: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used globally to manage pain and inflammation. The rising prevalence of polypharmacy and potential drug–drug interactions (pDDIs) magnified by the prolonged and irrational use of NSAIDs may jeopardize patient medication safety. This study aims to analyze the pattern in prescribing NSAIDs and assess the extent of polypharmacy and pDDIs in community pharmacies located in Ras Al Khaimah. Methods: A quantitative cross-sectional study was conducted in randomly selected community pharmacies over six months (July 2024 to December 2024). Prescriptions pertaining to NSAIDs were assessed for prescribing patterns; incidence of polypharmacy and pDDIs were identified using Lexicomp’s drug interaction database. Chi-square tests assessed associations between treatment variables and polypharmacy, while logistic regression explored predictors of pDDIs. Results: In a total of 600 prescriptions, 1865 drugs were prescribed, including 908 NSAIDs. Celecoxib (28.2%) and ketoprofen (27.6%) remained the most predominant oral and topical NSAIDs prescribed. Aspirin and celecoxib were most commonly linked with pDDIs. A total of 357 pDDIs were identified, averaging 1.87 ± 1.39 per prescription. Most were of minor severity (60.22%), risk category C (43.97%), and fair reliability (59.38%). Gender, nationality, and comorbidities were significantly associated with polypharmacy (p < 0.001). Logistic regression showed nationality (p = 0.016), comorbidities (p < 0.001), and drug count (p = 0.007) as key predictors of pDDIs. Conclusions: Frequent NSAIDs prescribing, incidence of polypharmacy, and pDDIs underscore the attention for more cautious, evidence-based prescribing practice. Enforcing a robust regulatory framework, coupled with strengthening medication-use policies and pharmacist-led thorough medication history review and ongoing monitoring is paramount to improve patient safety and clinical outcomes.
Keywords: cross-sectional study; poly pharmacy; drug interactions; non-steroidal anti-inflammatory drugs; prescriptions cross-sectional study; poly pharmacy; drug interactions; non-steroidal anti-inflammatory drugs; prescriptions

Share and Cite

MDPI and ACS Style

Shareef, J.; Sridhar, S.B.; Al Naqbi, S.H.; Bakshi, A.I. Beyond Pain Relief: A Cross-Sectional Study on NSAID Prescribing, Polypharmacy, and Drug Interaction Risks in Community Pharmacies. Healthcare 2025, 13, 3264. https://doi.org/10.3390/healthcare13243264

AMA Style

Shareef J, Sridhar SB, Al Naqbi SH, Bakshi AI. Beyond Pain Relief: A Cross-Sectional Study on NSAID Prescribing, Polypharmacy, and Drug Interaction Risks in Community Pharmacies. Healthcare. 2025; 13(24):3264. https://doi.org/10.3390/healthcare13243264

Chicago/Turabian Style

Shareef, Javedh, Sathvik Belagodu Sridhar, Saeed Humaid Al Naqbi, and Adyan Iftekhar Bakshi. 2025. "Beyond Pain Relief: A Cross-Sectional Study on NSAID Prescribing, Polypharmacy, and Drug Interaction Risks in Community Pharmacies" Healthcare 13, no. 24: 3264. https://doi.org/10.3390/healthcare13243264

APA Style

Shareef, J., Sridhar, S. B., Al Naqbi, S. H., & Bakshi, A. I. (2025). Beyond Pain Relief: A Cross-Sectional Study on NSAID Prescribing, Polypharmacy, and Drug Interaction Risks in Community Pharmacies. Healthcare, 13(24), 3264. https://doi.org/10.3390/healthcare13243264

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop